2023 Form 5500 filing — Convey Health Solutions 401(K) Plan
Plain-English filing summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20241106050628NAL0008692481001) for Convey Health Solutions 401(K) Plan, reported by United States Pharmaceutical Gro under EIN 65-1122695 and plan number 001. It reports 2,448 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).
Form 5500 2 · 2023
Filing snapshot
Net assets (EOY)$44.6MReported net assets$44,637,364
Participants2.4K2,448
Provider compensation$131.3K2 Schedule C row(s)$131,271
Schedules filedSchedule H, Schedule CLoaded schedules
- EFAST2 acknowledgement
- 20241106050628NAL0008692481001
- Plan sponsor
- United States Pharmaceutical Gro
- EIN
- 65-1122695
- Plan number
- 001
- Location
- Fort Lauderdale, FL
- Received date
- not reported in the loaded dataset
Schedule H · 2023
Reported financial snapshot
Reported figures as filed, in whole dollars. Only fields the filing reports are shown.
Reported balance (end of year)$44.6M total assets
Net assets$44.6MLiabilities$0
Full reported line items
- Total assets (EOY)
- $44,637,364
- Total liabilities (EOY)
- $0
- Net assets (EOY)
- $44,637,364
- Employer contributions
- $2,531,917
- Participant contributions
- $5,098,539
- Total income / additions
- $14,637,849
- Benefits paid
- $5,155,516
- Administrative expenses
- $131,272
- Total expenses
- $5,317,759
- Net increase / (decrease)
- $9,320,090
Schedule C
Reported service provider compensation
Compensation reported on the 2023 filing, ranked by reported total.
- 1
- 2